Nazlı Hacıağaoğlu

Nazlı Hacıağaoğlu

Auto-generated profile, based on publicly available information

Nazlı Hacıağaoğlu

UNIVERSITY OF HEALTH SCIENCES, İSTANBUL KARTAL DR. LÜTFİ KIRDAR HEALTH RESEARCH CENTER, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF FAMILY MEDICINE

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2022 in Turkish Journal of Family Medicine and Primary Care
Verified
Journal Article
Open access
PDF file
SÇSema Gizem Çalişkan
Sema Gizem Çalişkan
NHNazlı HACIAĞAOĞLU
Nazlı HACIAĞAOĞLU
STSabah Tuzun
Sabah Tuzun
CÖCan Öner
Can Öner
EŞEngin Ersin Şi̇mşek
Engin Ersin Şi̇mşek
HCHuseyin Ceti̇n
Huseyin Ceti̇n
Giriş: Bu çalışma aile hekimliği yönelimli diyabet merkezi (AHYDM) ile hastane yönelimli diyabet merkezi (HYDM)’den takipli tip 2 diabetes mellitus (DM) hastalarında hipoglisemi sıklığı ve ilişkili faktörlerin karşılaştırılmasını amaçlamaktadır. Yöntem: Bu çalışmaya 1 Aralık 2017– 31 Aralık 2019 tarihleri arasında aynı hastaneye bağlı olan iki diyabet merkezine başvuran Tip 2DM hastaları dahil edilmiştir. Çalışmada hastane içerisinde yer alan ve İç Hastalıkları Kliniği tarafından yürütülen DM merkezi HYDM olarak kabul edilirken, hastane kampüsü dışında bulunan, Aile Hekimliği Kliniği tarafından yürütülen DM merkezi ise AHYDM olarak kabul edilmiştir. Her iki merkezdeki açlık plazma glukozu düzeyi en az iki defa 70 mg/dL’nin altında saptanan hastalar vaka grubuna dahil edilmiştir. Ardından, her bir merkezde vaka grubundaki hastalara yaş ve cinsiyet açısından eşleştirilmiş, hipoglisemi atağı bulunmayan Tip 2 DM hastaları kontrol grubu olarak kabul edilmiştir. Ayrıca, Hipoglisemi Korku Ölçeği (HKÖ) iki merkezdeki vaka grubuna da uygulanmıştır. Bulgular: Çalışmaya dahil edilen 240 hastanın 150 (%62,5)’si kadın idi. HYDM’deki tüm hastaların 53(%1,2)’ünde hipoglisemi saptanmışken, AHYDM’den katılan tüm hastaların 27(%0,31)’sinde hipoglisemi tespit edilmiştir. Her iki merkezdeki vaka grubunda DM süresi, insülin kullanım sıklığı ve toplam insülin dozu kontrol grubundan yüksekti (sırasıyla, HYDM için p=0,049, p<0,001, p=0,001; AHYDM için p=0,014, p0,05). Sonuç: DM hastalarında, özellikle insülin kullanan ve T2DM süresi uzun olan hastalarda hipoglisemi açısından dikkatli değerlendirilmesi gereklidir. Ayrıca hastaların aile hekimleri tarafından hipoglisemi ile ilgili eğitilmesi hipoglisemi görülme sıklığını azaltabilir.

23 December 2022 in Family Practice
Verified
Journal Article
Open access
PDF file
MKMeltem Karakulak Kafkas
Meltem Karakulak Kafkas
STSabah Tuzun
Sabah Tuzun
NHNazlı Hacıağaoğlu
Nazlı Hacıağaoğlu
HÇHüseyin Çetin
Hüseyin Çetin
SCSevda Şener Cömert
Sevda Şener Cömert
EŞEngin Ersin Şimşek
Engin Ersin Şimşek
The effect of COVID-19 infection on pulmonary function is unknown. This study aimed to evaluate pulmonary function tests (PFTs) of patients hospitalized with the diagnosis of COVID-19 pneumonia at 3 and 6 months post-discharge. Patients aged 18 years and over who had positive COVID-19 PCR test results and were hospitalized in the pandemic service between 1 May 2020 and 31 October 2020, were included in the study. All patients were evaluated with PFTs FVC, FEV1, FEV1/FVC, and FEF25–75 at 3 and 6 months after discharge. The mean age of 34 patients included in the study was 47.7 ± 12.7 years. The FVC, FEV1, FEV1/FVC, and FEF25–75 measurements at 3 and 6 months post-discharge showed no significant difference (P = 0.765, P = 0.907, P = 0.707, and P = 0.674, respectively). There was no significant difference in any PFT measurements at the third month follow-up, regardless of the pharmacological treatment protocols applied during hospitalization (P > 0.05). However, FEV1/FVC and FEF25–75 levels were 83.1 [3.4]% and 91.0 [10.0]%, respectively, in those who received systemic steroid treatment, and 78.3 ± 8.5% and 72.5 ± 25.7% in those who did not (P = 0.019 and P = 0.048, respectively). In addition, FVC and FEV1 levels increased significantly from the third to the sixth month follow-up in patients who received systemic steroid therapy (P = 0.035 and P = 0.018, respectively). Although there is no significant difference in PFT measurements from 3 to 6 months in COVID-19 patients, systemic steroid therapy may have a beneficial effect on respiratory function in COVID-19 patients.

19 September 2024 in Health Education Research
Verified
Journal Article
Closed access
PDF file
ZAZarif Cagla Arslan
Zarif Cagla Arslan
STSabah Tuzun
Sabah Tuzun
CÖCan Öner
Can Öner
NHNazli Haciağaoğlu
Nazli Haciağaoğlu
HÇHüseyin Çetin
Hüseyin Çetin
EŞEngin Ersin Şimşek
Engin Ersin Şimşek
Although various approaches have been used in diabetes self-management education (DSME) programs, the effect of DSME programs on glycemic control is controversial. This study aimed to compare the effects of structured individual education and combined education on glycemic regulation in type 2 diabetes mellitus (T2DM). This study included T2DM patients who applied to the Ust Kaynarca Diabetes Center between 1 January 2018 and 11 March 2020. All data were retrospectively evaluated from hospital information systems. Patients who received only individual education were defined as the individual education group (IEG), and patients who received both individual and group education were defined as the combined education group (CEG). A total of 496 T2DM patients, with 248 (50.0%) in the IEG and 248 (50.0%) in the CEG, were included in the study. The change in HbA1c (ΔHbA1c) value for the IEG was 1.0% (2.5%), while the ΔHbA1c value for the CEG was 1.9% (2.8%) (P < 0.001). When factors affecting the glycemic control were evaluated, it was determined that the type of education [odds ratio (OR) = 2.295, P < 0.001], gender (OR = 1.799, P = 0.007), presence of hyperlipidemia (OR = 0.559, P = 0.032) and presence of medications added to treatment (OR = 1.558, P = 0.041) were effective on glycemic control. Combined education, in which individual and group education are conducted together, is more effective than individual education in glucose regulation.

29 January 2026 in Turkish Journal of Family Medicine and Primary Care
Verified
Journal Article
Closed access
DSDerya Karadeniz Sir
Derya Karadeniz Sir
HCHuseyin Cetin
Huseyin Cetin
CÖCan Öner
Can Öner
NHNazlı Hacıağaoğlu
Nazlı Hacıağaoğlu
Objective: To evaluate cancer screening behaviors among patients diagnosed with breast, cervical, or colorectal cancer and identify factors influencing screening participation.Materials and Methods: This cross-sectional descriptive study included 470 patients diagnosed with breast, cervical, or colorectal cancer at a hospital in Istanbul between June and December 2021. Data were collected via face-to-face interviews using a researcher-developed questionnaire based on the literature. Results: Most participants were women, with variations in age, marital status, and education levels. Screening rates were 55% for breast cancer, 57% for cervical cancer, and 33% for colorectal cancer, with statistically significant differences across cancer types. Fears of cancer and family history were positively associated with screening uptake. Conclusion: Screening participation was higher for breast and cervical cancer than for colorectal cancer. Regular visits to family physicians, fear of cancer, family history, and healthcare professional recommendations were key determinants of screening behavior. Enhancing the role of primary care and increasing public awareness may improve early cancer detection.

1 January 2024 in European Journal of Human Health
Verified
Journal Article
Closed access
ASAli Riza Say
Ali Riza Say
NHNazli Haciagaoglu
Nazli Haciagaoglu
HCHuseyin Ceti̇n
Huseyin Ceti̇n
CÖCan Öner
Can Öner
ESEngin Ersin Simsek
Engin Ersin Simsek
Aim: The aim of the study was to evaluate the relationship between COVID-19 and early sleep quality and to reveal the influencing factors. Methods: This cross-sectional study included 443 participants. The COVID-19 history and sociodemographic characteristics of the participants were evaluated, and the Pittsburgh Sleep Quality Index (PSQI) was administered. Results: The participants included 234 (52.8%) women and 209 (47.2%) men, and the mean age was 40.7±13.7 years. The mean PSQI scores of the participants were 3.7±4.1 and 220 (49.7%) had poor sleep quality. Individuals who had been infected with COVID-19 had significantly worse sleep quality compared to those who have never been infected or those who had only been in contact (p=0.015). The Multivariate Binary Logistic Regression Analysis found that female gender and actively working improved sleep quality (p=0.013, p=0.039). It was also determined that COVID-19 infection history resulted in poor sleep quality (p=0.010). Conclusions: COVID-19 infection was associated with worse sleep quality in the early period compared to those who had not been infected or had only been in contact. With holistic approach modeling, family physicians should conduct screenings using appropriate scales to evaluate the quality of life of disadvantaged groups in primary care, and the relevant segments of society, especially health professionals, should be encouraged to increase the quality of life of the individuals at risk.